Upperton Pharma Solutions is the winner of the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.
India is the largest supplier of generic medicines globally, accounting for one in five generic drugs sold worldwide, and has earned the title “pharmacy of the world”. Dr. Jayashree Aiyar, chief scientific officer, Syngene International discusses.
Aragen, a contract research, development and manufacturing organisation (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from late July 2025.
Kivu Bioscience, a biotech company developing next-generation antibody-drug conjugates, has announced a manufacturing partnership with Sterling Pharma Solutions, a global contract development and manufacturing organisation (CDMO).
Aragen, a contract research, development and manufacturing organisation (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from July 2025.
European Pharmaceutical Manufacturer asks John McDermott, vice president of scientific consulting at Quotient Sciences what the benefits are of using a CRDMO?
Shilpa Biologicals, a full-service contract development and manufacturing organisation (CDMO), announces the opening of a dedicated bioconjugation suite at its Dharwad site in India.
Kaida BioPharma, an earlystage pharma company dedicated to advancing targeted anti-cancer therapies to address hormone-driven cancers affecting women, has entered into a manufacturing agreement with Northway Biotech, for the manufacturing of KAD101.
